Related Experiment Video

Updated: Jun 13, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Brain development in children with new onset epilepsy: a prospective controlled cohort investigation

Bruce P Hermann1, Kevin Dabbs, Tara Becker

  • 1Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA. hermann@neurology.wisc.edu

Epilepsia
|April 14, 2010
PubMed

Insights

Children with recent-onset epilepsy show delayed white matter volume increase in the brain, impacting development and cognitive function. This contrasts with healthy children

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Pediatric Neurology

Background:

  • Epilepsy in children can impact brain development.
  • Understanding neurodevelopmental trajectories is crucial for early intervention.
  • Previous studies have not fully characterized prospective brain structural changes in new-onset epilepsy.

Purpose of the Study:

  • To prospectively assess neurodevelopmental changes in brain structure in children with new/recent-onset epilepsy.
  • To compare brain structural development between children with epilepsy and healthy controls.
  • To investigate differences in gray and white matter volume changes over time.

Main Methods:

  • Longitudinal magnetic resonance imaging (MRI) study.
  • 38 children with new/recent-onset idiopathic epilepsy and 34 healthy controls (mean age 12.9 years).
  • MRI scans at baseline and 2-year follow-up, analyzing total cerebral and lobar gray and white matter volumes.

Main Results:

  • Gray matter volume reduction was comparable between groups.
  • Healthy controls showed significant white matter volume increase, particularly in frontal, parietal, and temporal lobes.
  • Children with epilepsy exhibited blunted white matter volume increase, with significant group differences in total cerebrum and frontal lobe white matter.

Conclusions:

  • Children with new/recent-onset epilepsy display altered brain development with delayed white matter maturation.
  • This altered development may impair brain connectivity and executive functions.
  • Findings highlight the need for monitoring neurodevelopmental trajectories in pediatric epilepsy.
Abstract

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe06:04

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

Published on: August 16, 2024

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...